Physician profile
Patrick J Hall
NPI 1194725143
$2,323.69
in general payments reported to CMS, 2019-2025
25 companies · $429 in 2025
The $429 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $437 · 2020: $153 · 2021: $205 · 2022: $364 · 2023: $444 · 2024: $291 · 2025: $429.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,164.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,164.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $535.26 | 2021-2025 | Nucala, Trelegy Ellipta |
| Optinose US, INC. | $498.27 | 2019-2025 | |
| Alk-Abello, INC | $398.43 | 2019-2023 | Grastek, Ragwitek, Odactra |
| Genzyme Corporation | $263.90 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $121.84 | 2019-2022 | |
| Medtronic USA, INC. | $94.97 | 2019 | |
| Smith+Nephew, INC. | $68.61 | 2022-2024 | Tula |
| Merck Sharp & Dohme LLC | $40.05 | 2021-2023 | |
| Dompe US, INC. | $29.70 | 2025 | Oxervate |
| Kaleo, INC. | $27.74 | 2019-2022 | |
| Medtronic, INC. | $24.31 | 2023 | Ligasure |
| Boston Scientific Corporation | $24.02 | 2024 | Watchman Flx |
| Aerin Medical INC. | $20.75 | 2025 | |
| Lilly USA, LLC | $18.44 | 2025 | Zepbound |
| Paratek Pharmaceuticals, INC. | $17.90 | 2025 | Xhance |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pharming Healthcare, INC. | $16.91 | 2023 | Ruconest |
| Hikma Pharmaceuticals USA | $14.72 | 2023 | Ryaltris |
| Intersect Ent, INC. | $14.54 | 2020 | |
| Novartis Pharmaceuticals Corporation | $14.26 | 2019 | |
| Cochlear Americas | $13.82 | 2025 | Baha, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Osia Osi300 Implant |
| Csl Behring | $13.46 | 2023 | Hizentra |
| Acclarent, INC | $13.29 | 2023 | Trudi Nav Cable, Acclarent Aera |
| Cook Medical LLC | $13.00 | 2019 | |
| Glenmark Therapeutics INC. | $13.00 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Hall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.